Queen Mary University of London

Organisation as named by public health-data sources.

Records naming this organisation

• This evaluation will help to monitor the screening processes and outcomes in the six pilot sites across England involved in a pilot of HPV-based cervical screening. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-04-10)
• This project will measure the benefit of the NHS National Breast Screening including the effect on breast cancer mortality and whether there is a serious negative effect, in terms of over-diagnosis. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-06-01)
• This project will study the impact of the current NHS Bowel Cancer Screening Programme on the incidence (frequency) of advanced primary colorectal cancer. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-08-14)
• This project will measure the benefit of the NHS National Breast Screening including the effect on breast cancer mortality and whether there is a serious negative effect, in terms of over-diagnosis. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-08-14)
• This project will measure the benefit of the NHS National Breast Screening including the effect on breast cancer mortality and whether there is a serious negative effect, in terms of over-diagnosis. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-09-25)
• A clinical audit of the Wolfson Institute of Preventive Medicine (WIPM) Antenatal Screening Service to estimate the detection rate and false positive rate for Down’s Syndrome, Trisomy 18 and Trisomy… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2017-09-28)
• This project will study the impact of the current NHS Bowel Cancer Screening Programme on the incidence (frequency) of advanced primary colorectal cancer. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-03-21)
• This project will study the impact of the current NHS Bowel Cancer Screening Programme on the incidence (frequency) of advanced primary colorectal cancer. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-03-21)
• This project will measure the benefit of the NHS National Breast Screening including the effect on breast cancer mortality and whether there is a serious negative effect, in terms of over-diagnosis. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-06-25)
• This project will study the impact of the current NHS Bowel Cancer Screening Programme on the incidence (frequency) of advanced primary colorectal cancer. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-07-24)
• This study will look to establish and quantify what factors influence the concentration of haemoglobin (blood) that is picked up through a new screening test, called the Faecal Immunochemical Test (F… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-11-26)
• A national clinical audit to look at cancers diagnosed between routine mammograms provided by the NHS Breast Screening Programme. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2018-12-21)
• This evaluation aims to inform local decision-making on the diagnosis and treatment of patients with lung cancer in North East – North Central London, leading to earlier diagnosis and an increase in… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-03-28)
• This evaluation aims to inform local decision-making on the diagnosis and treatment of patients with lung cancer in North East – North Central London, leading to earlier diagnosis and an increase in… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2019-05-14)
• A national clinical audit to look at cancers diagnosed between routine mammograms provided by the NHS Breast Screening Programme. (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-01-14)
• A clinical trial to look at whether patients are more likely to complete treatment for Latent Tuberculosis Infection (LTBI) if they are managed in primary care (by their GP) compared to secondary car… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-02-17)
• This evaluation aims to inform local decision-making on the diagnosis and treatment of patients with lung cancer in North East – North Central London, leading to earlier diagnosis and an increase in… (Registered study, PHE data release register (2017 to 2020) and UKHSA approvals register (2022 to 2024), 2020-04-24)

Organisation name as the register gives it. Not matched to a company or institutional identifier here; the same organisation may appear under other spellings.